1. Keightley, A M, Lam, Y M, Brady, J N, Cameron, C L, Lillicrap, D. . Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. In Blood, 93, 4277-83. doi:. https://pubmed.ncbi.nlm.nih.gov/10361125/
2. Zhao, Yawei, He, Meihui, Cui, Lianzhi, Zhang, Hansi, Chen, Li. 2024. Systematic screening of protein-coding gene expression identified VWF as a potential key regulator in anthracycline-based chemotherapy-exacerbated metastasis of breast cancer. In BMC cancer, 24, 1243. doi:10.1186/s12885-024-12999-9. https://pubmed.ncbi.nlm.nih.gov/39379897/
3. Cabrera, Noelia, Casaña, Pilar, Cid, Ana Rosa, Moret, Andrés, Aznar, Jose Antonio. 2008. Novel missense mutation c.2685G>C (p.Q895H) in VWF gene associated with very low levels of VWF mRNA. In Annals of hematology, 88, 245-7. doi:10.1007/s00277-008-0576-7. https://pubmed.ncbi.nlm.nih.gov/18712522/
4. Johansson, Anna M, Halldén, Christer, Säll, Torbjörn, Lethagen, Stefan. 2011. Variation in the VWF gene in Swedish patients with type 1 von Willebrand Disease. In Annals of human genetics, 75, 447-55. doi:10.1111/j.1469-1809.2011.00652.x. https://pubmed.ncbi.nlm.nih.gov/21534937/
5. Castaman, Giancarlo, Federici, Augusto B. 2016. Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality. In Seminars in thrombosis and hemostasis, 42, 478-82. doi:10.1055/s-0036-1579638. https://pubmed.ncbi.nlm.nih.gov/27148840/